Posttraumatic Anterior Hypopituitarism—Revisited: The Role of TRH Provocative Release of Prolactin in the Confirmation of Anterior Pituitary Damage

PEDIATRICS ◽  
1977 ◽  
Vol 59 (6) ◽  
pp. 948-950
Author(s):  
David R. Brown ◽  
J. Michael McMillin
Keyword(s):  
Pituitary Gland ◽  
Anterior Pituitary ◽  
Thyroid Stimulating Hormone ◽  
Anterior Pituitary Gland ◽  
Serum Prolactin ◽  
Pituitary Insufficiency ◽  
Closed Head Trauma ◽  
One Year ◽  
Stimulating Hormone

We have previously reported a case of anterior pituitary insufficiency in a 14-year-old girl following closed head trauma.1 Endocrine evaluation one year after her accident revealed hypopituitarism manifested by cachexia, hypothyroidism, hypogonadism, and hypoadrenocorticism. Laboratory studies demonstrated deficiencies of adrenocorticotropic hormone, thyroid-stimulating hormone (TSH), growth hormone, and gonadotropic hormones (follicle-stimulating hormone and luteinizing hormone). We postulated that her hypopituitarism was due to anterior pituitary gland destruction rather than stalk section or hypothalamic damage. We have recently measured her serum prolactin concentrations following provocative stimulation with thyrotropin-releasing hormone (TRH), and these results strengthen the evidence for direct anterior pituitary gland destruction and provide a more complete delineation of her endocrinologic function.

scholarly journals BODY IMMUNOPROPHYLAXIS OF PREGNANT AND NEWLY-CALVED COWS

REPORTS ◽  
2021 ◽  
Vol 335 (1) ◽  
pp. 39-46
Author(s):  
V.G. Semenov ◽  
V.G. Tyurin ◽  
D.A. Baimukanov ◽  
E.P. Simurzina ◽  
S.G. Kondruchina ◽  
...  
Keyword(s):  
Pituitary Gland ◽  
Anterior Pituitary ◽  
Thyroid Stimulating Hormone ◽  
Anterior Pituitary Gland ◽  
The Body ◽  
Macrophage Receptors ◽  
Service Period ◽  
New Generation ◽  
Opening Up ◽  
Stimulating Hormone

The research was performed to identify the most effective bio immunostimulant. We used PS-2 and Prevention-N-E biologicals developed on the basis of the Chuvash State Agrarian University, as well as widely used in veterinary practice - PDE and E-selenium. Injection of PS-2 and Prevention-NE preparations to dry cows at a dose of 10.0 ml three times 45-40, 25-20 and 15-10 days before calving, as well as PDE and E-selenium at a dose of 20.0 and 10.0 ml 20 days before calving, respectively, prevents postpartum diseases. The mechanism of action of the PS-2 and Prevention-N-E drugs developed and tested by us is manifested, first of all, due to the consecutive processes of macrophage activation, as a result of the action of polysaccharide corpuscles and drug components on macrophage receptors. Secondly, information from the receptors of macrophages and chemoreceptors is transmitted along the afferent pathway to the cerebral cortex, then the signals go to the hypothalamus, which leads to liberin secretion by the nuclei of the ashen tuber of the hypothalamus. Liberins, in turn, increase the release of hormones by the anterior pituitary gland - the adenohypophysis. The anterior pituitary gland releases tropic hormones: somatotropic hormone, adrenocorticotropic hormone, thyroid-stimulating hormone, follicle-stimulating hormone, etc. These hormones are involved in metabolic processes in the body. Under the influence of preparations, in cows the time of membranes sweep was reduced, the risk of uterus subinvolution and endometritis decreased. In cows, the timing of the onset of estrus, the insemination rate, and the service period were shortened, and the conception rate increased in one estrus. In such a way, against the background of the use of biologicals with the help of nonspecific adaptive reactions, the body retains the relative constancy of the internal environment necessary for life - homeostasis, and it actively resists the adverse effects of the external environment, increasing its phylactic power. Consequently, new opportunities are opening up for the implementation of the reproductive and productive qualities of cattle due to the body immunoprophylaxis with complex biological products of a new generation.

Pituitary tumours

2019 ◽  
pp. 299-320
Author(s):  
Kanna Gnanalingham ◽  
Zsolt Zador ◽  
Tara Kearney ◽  
Federico Roncaroli ◽  
H. Rao Gattamaneni
Keyword(s):  
Pituitary Gland ◽  
Anterior Pituitary ◽  
Horizontal Plane ◽  
Third Ventricle ◽  
Sella Turcica ◽  
Thyroid Stimulating Hormone ◽  
Posterior Lobe ◽  
Recommended Treatment ◽  
Stimulating Hormone

The pituitary gland occupies the sella turcica, approximately 5 cm posterior to the tip of the nose in the midline of the skull base. It is closely related to the hypothalamus and third ventricle superiorly, chiasm and lamina terminalis anterosuperiorly, sphenoid sinus anteroinferiorly, cavernous sinus and cavernous segment of the carotid artery laterally, the posterior clinoids and clivus posteriorly. There are two distinct components to the pituitary gland, the anterior and posterior lobe, which are derived from the ectoderm and neuroectoderm, respectively. The anterior pituitary constitutes 80% of the gland mass and in the horizontal plane it is distributed into two lateral wings. The hormones produced by the anterior pituitary are adrenocorticotropic hormone, prolactin, growth hormone, thyroid-stimulating hormone, follicle-stimulating hormone, and luteinizing hormone. This chapter looks in detail at the role of the pituitary gland, what happens when it becomes tumorous, and the recommended treatment avenues.

Latest data on the role of the anterior pituitary gland in metabolism

1935 ◽  
Vol 31 (11-12) ◽  
pp. 1325-1337
Author(s):  
E. R. Mogilevsky
Keyword(s):  
Pituitary Gland ◽  
Anterior Pituitary ◽  
Anterior Pituitary Gland ◽  
Endocrine Glands ◽  
Metabolic Hormones

If we consider the commanding position which the pituitary gland according to modern views occupies in the system of endocrine glands, and compare this with the role which many endocrine glands play in metabolism, then numerous attempts to isolate from the pituitary gland special hormones regulating metabolism will be completely understandable and natural. The search for special metabolic hormones in the pituitary gland is all the more justified because a number of clinical facts have directly suggested the involvement of the pituitary gland in metabolism.

Prolactin release, oestrogens and proliferation of prolactin-secreting cells in the anterior pituitary gland of adult male rats

1986 ◽  
Vol 108 (3) ◽  
pp. 399-403 ◽  
Author(s):  
R. L. Pérez ◽  
G. A. Machiavelli ◽  
M. I. Romano ◽  
J. A. Burdman
Keyword(s):  
Cell Proliferation ◽  
Pituitary Gland ◽  
Adult Male ◽  
Anterior Pituitary ◽  
Pituitary Hormones ◽  
Anterior Pituitary Gland ◽  
Male Rats ◽  
Serum Prolactin ◽  
Prolactin Release ◽  
Experimental Conditions

ABSTRACT Relationships among the release of prolactin, the effect of oestrogens and the proliferation of prolactin-secreting cells were studied under several experimental conditions. Administration of sulpiride or oestradiol released prolactin and stimulated cell proliferation in the anterior pituitary gland of adult male rats. Clomiphene completely abolished the rise in cell proliferation, but did not interfere with the sulpiride-induced release of prolactin. Treatment with oestradiol plus sulpiride significantly increased serum prolactin concentrations and the mitotic index compared with the sum of the stimulation produced by both drugs separately. Bromocriptine abolished the stimulatory effect of oestradiol on the serum prolactin concentration and on cell proliferation. In oestradiol- and/or sulpiride-treated rats, 80% of the cells in mitoses were lactotrophs. The remaining 20% did not stain with antisera against any of the pituitary hormones. The number of prolactin-secreting cells in the anterior pituitary gland significantly increased after the administration of oestradiol or sulpiride. The results demonstrate that treatment with sulpiride and/or oestradiol increases the proliferation and the number of lactotrophs in the anterior pituitary gland of the rat. J. Endocr. (1986) 108, 399–403

Physiological role of galanin in the regulation of anterior pituitary function in humans

1994 ◽  
Vol 266 (1) ◽  
pp. E57-E61 ◽  
Author(s):  
A. Giustina ◽  
M. Licini ◽  
M. Schettino ◽  
M. Doga ◽  
G. Pizzocolo ◽  
...  
Keyword(s):  
Anterior Pituitary ◽  
Physiological Role ◽  
Thyroid Stimulating Hormone ◽  
Pituitary Function ◽  
Slight Reduction ◽  
Baseline Serum ◽  
Releasing Hormone ◽  
Anterior Pituitary Function ◽  
Stimulating Hormone

The aim of our study was to elucidate the physiological role of the neuropeptide galanin in the regulation of anterior pituitary function in human subjects. Six healthy men (age range 26-35 yr, body mass index range 20-24 kg/m2) underwent in random order 1) an intravenous bolus injection of growth hormone-releasing hormone (GHRH)-(1-29)-NH2 (100 micrograms) + thyrotropin-releasing hormone (TRH, 200 micrograms) + luteinizing hormone-releasing hormone (LHRH, 100 micrograms) + corticotropin-releasing hormone (CRH, 100 micrograms), and 2) intravenous saline (100 ml) at time 0 plus either human galanin (500 micrograms) in saline (100 ml) or saline (100 ml) from -15 to +30 min. Human galanin determined a significant increase in serum GH (GH peak: 11.3 +/- 2.2 micrograms/l) from both baseline and placebo levels. No significant differences were observed between GH values after galanin and those after GHRH alone (24.3 +/- 5.2 micrograms/l). Human galanin significantly enhanced the GH response to GHRH (peak 49.5 +/- 10 micrograms/l) with respect to either GHRH or galanin alone. Human galanin caused a slight decrease in baseline serum adrenocorticotropic hormone (ACTH; 16.3 +/- 2.4 pg/ml) and cortisol levels (8 +/- 1.5 micrograms/dl). Galanin also determined a slight reduction in both the ACTH (peak 27 +/- 8 pg/ml) and cortisol (peak 13.8 +/- 1.3 micrograms/dl) responses to CRH. Baseline and releasing hormone-stimulated secretions of prolactin, thyroid-stimulating hormone, LH, and follicle-stimulating hormone were not altered by galanin. Our data suggest a physiological role for the neuropeptide galanin in the regulation of GH secretion in humans.(ABSTRACT TRUNCATED AT 250 WORDS)

Sign in / Sign up

Export Citation Format

Share Document